QCM
JBIO

Quantinno Capital Management’s Jade Biosciences JBIO Stock Holding History

Quantinno Capital Management’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55M Buy
114,716
+84,165
+275% +$1.76M ﹤0.01% 1755
2026
Q1 		$429K Buy
30,551
+1,059
+4% +$15.3K ﹤0.01% 2825
2025
Q4 		$455K Buy
29,492
+2,517
+9% +$29.5K ﹤0.01% 2517
2025
Q3 		$233K Buy
26,975
+4,989
+23% +$40.8K ﹤0.01% 2649
2025
Q2 		$220K Buy
+21,986
New +$748K ﹤0.01% 2283

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quantinno Capital Management's JBIO Position: Q2 2026 in Review

Quantinno Capital Management increased its Jade Biosciences (JBIO) stake by 275% in Q2 2026, buying an estimated $1.76M and bringing the position to 114,716 shares worth $2.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1755.

Quantinno Capital Management first reported a position in JBIO in Q2 2025 and has held it in 5 quarters since. 153 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Quantinno Capital Management held 114,716 shares of Jade Biosciences worth $2.55M as of Q2 2026.
  • Quantinno Capital Management bought 84,165 Jade Biosciences shares in Q2 2026, an estimated $1.76M.
  • Jade Biosciences made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1755 holding.
  • Quantinno Capital Management first reported a position in Jade Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 153 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.